Ana Kostić

1.4k total citations · 1 hit paper
22 papers, 767 citations indexed

About

Ana Kostić is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Ana Kostić has authored 22 papers receiving a total of 767 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 5 papers in Molecular Biology and 4 papers in Surgery. Recurrent topics in Ana Kostić's work include Autism Spectrum Disorder Research (4 papers), CAR-T cell therapy research (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Ana Kostić is often cited by papers focused on Autism Spectrum Disorder Research (4 papers), CAR-T cell therapy research (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Ana Kostić collaborates with scholars based in United States, Serbia and United Kingdom. Ana Kostić's co-authors include George D. Yancopoulos, Allen Radin, Jennifer D. Hamilton, Neil M.H. Graham, Nikhil Dhingra, Gianluca Pirozzi, Xuan Li, Irma Cardinale, James G. Krueger and Emma Guttman‐Yassky and has published in prestigious journals such as Neuron, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Ana Kostić

22 papers receiving 751 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Dupilumab improves the molecular signature in skin of patients with moderate-to-severe atopic dermatitis

2014 359 citations Jennifer D. Hamilton, Mayte Suárez‐Fariñas et al. Journal of Allergy and Clinical Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ana Kostić United States	11	322	292	206	199	136	22	767
Man-Ru Liu China	7	211 0.7×	165 0.6×	199 1.0×	292 1.5×	449 3.3×	7	1.1k
Ahu Turkoz United States	7	242 0.8×	77 0.3×	90 0.4×	280 1.4×	109 0.8×	9	652
Tatiana Ecoiffier United States	13	116 0.4×	123 0.4×	108 0.5×	130 0.7×	145 1.1×	15	759
U. Häuser Germany	12	28 0.1×	258 0.9×	284 1.4×	153 0.8×	73 0.5×	26	826
Maria Antsiferova Switzerland	12	65 0.2×	32 0.1×	89 0.4×	290 1.5×	157 1.2×	14	709
Akiko Arakawa Japan	13	266 0.8×	13 0.0×	142 0.7×	265 1.3×	492 3.6×	24	952
Atsuko Maeda Japan	12	21 0.1×	127 0.4×	91 0.4×	307 1.5×	200 1.5×	14	801
Ele Prans Estonia	17	81 0.3×	21 0.1×	60 0.3×	264 1.3×	236 1.7×	38	740
Sebastian Drube Germany	14	25 0.1×	57 0.2×	83 0.4×	186 0.9×	282 2.1×	32	555
Hiroto Obata Japan	15	28 0.1×	75 0.3×	66 0.3×	326 1.6×	40 0.3×	24	890

Countries citing papers authored by Ana Kostić

Since Specialization

Citations

This map shows the geographic impact of Ana Kostić's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Kostić with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Kostić more than expected).

Fields of papers citing papers by Ana Kostić

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana Kostić. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Kostić. The network helps show where Ana Kostić may publish in the future.

Co-authorship network of co-authors of Ana Kostić

This figure shows the co-authorship network connecting the top 25 collaborators of Ana Kostić. A scholar is included among the top collaborators of Ana Kostić based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana Kostić. Ana Kostić is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Huang, Yong, Minghui Wang, Jinglong Zhang, et al.. (2024). Regulation of cell distancing in peri-plaque glial nets by Plexin-B1 affects glial activation and amyloid compaction in Alzheimer’s disease. Nature Neuroscience. 27(8). 1489–1504. 14 indexed citations

Sloofman, Laura, Tess Levy, Hannah E. Walker, et al.. (2024). Transient peripheral blood transcriptomic response to ketamine treatment in children with ADNP syndrome. Translational Psychiatry. 14(1). 307–307. 1 indexed citations

Palomba, M. Lia, Tanya Siddiqi, Leo I. Gordon, et al.. (2024). Lisocabtagene Maraleucel (liso-cel) in Patients (Pt) with R/R MCL: Subgroup Analyses in Pts with High-Risk Disease Features from the MCL Cohort of the TRANSCEND NHL 001. Transplantation and Cellular Therapy. 30(2). S14–S14. 2 indexed citations

Frank, Yitzchak, et al.. (2023). Gait Abnormalities in Children with Phelan-McDermid Syndrome. Journal of Child Neurology. 38(13-14). 665–671. 1 indexed citations

Kolevzon, A lexander, Tess Levy, Sandra Bedrosian‐Sermone, et al.. (2022). An open-label study evaluating the safety, behavioral, and electrophysiological outcomes of low-dose ketamine in children with ADNP syndrome. Human Genetics and Genomics Advances. 3(4). 100138–100138. 11 indexed citations

Kostić, Ana, Pierre Baillargeon, Virneliz Fernández-Vega, et al.. (2022). Screening for modulators of autism spectrum disorder using induced human neurons. SLAS DISCOVERY. 27(2). 128–139. 6 indexed citations

Tang, Lara, Tess Levy, Sylvia Guillory, et al.. (2021). Prospective and detailed behavioral phenotyping in DDX3X syndrome. Molecular Autism. 12(1). 36–36. 29 indexed citations

Shamji, Mohamed H., Janice A. Layhadi, Angeliki Karamani, et al.. (2021). Passive Prophylactic Administration with a Single Dose of Anti–Fel d 1 Monoclonal Antibodies REGN1908–1909 in Cat Allergen–induced Allergic Rhinitis: A Randomized, Double-Blind, Placebo-controlled Clinical Trial. American Journal of Respiratory and Critical Care Medicine. 204(1). 23–33. 55 indexed citations

Kostić, Ana & Joseph D. Buxbaum. (2021). The promise of precision medicine in autism. Neuron. 109(14). 2212–2215. 12 indexed citations

10.

Živanović, Dragoljub, et al.. (2021). Importance of a Follow-Up Ultrasound Protocol in Monitoring Posttraumatic Spleen Complications in Children Treated with a Non-Operative Management. Medicina. 57(8). 734–734. 7 indexed citations

11.

Kostić, Ana, et al.. (2017). A first‐in‐human pharmacodynamic and pharmacokinetic study of a fully human anti‐glucagon receptor monoclonal antibody in normal healthy volunteers. Diabetes Obesity and Metabolism. 20(2). 283–291. 24 indexed citations

12.

Papadopoulos, Kyriakos P., Robin Kate Kelley, Anthony W. Tolcher, et al.. (2015). A Phase I First-in-Human Study of Nesvacumab (REGN910), a Fully Human Anti–Angiopoietin-2 (Ang2) Monoclonal Antibody, in Patients with Advanced Solid Tumors. Clinical Cancer Research. 22(6). 1348–1355. 59 indexed citations

13.

Chiorean, E. Gabriela, Patricia LoRusso, Robert Matthew Strother, et al.. (2015). A Phase I First-in-Human Study of Enoticumab (REGN421), a Fully Human Delta-like Ligand 4 (Dll4) Monoclonal Antibody in Patients with Advanced Solid Tumors. Clinical Cancer Research. 21(12). 2695–2703. 114 indexed citations

14.

Fathi, Amir T., Uma Borate, Daniel J. DeAngelo, et al.. (2015). A Phase 1 Study of Denintuzumab Mafodotin (SGN-CD19A) in Adults with Relapsed or Refractory B-Lineage Acute Leukemia (B-ALL) and Highly Aggressive Lymphoma. Blood. 126(23). 1328–1328. 35 indexed citations

15.

Hamilton, Jennifer D., Mayte Suárez‐Fariñas, Nikhil Dhingra, et al.. (2014). Dupilumab improves the molecular signature in skin of patients with moderate-to-severe atopic dermatitis. Journal of Allergy and Clinical Immunology. 134(6). 1293–1300. 359 indexed citations breakdown →

16.

Papadopoulos, Kyriakos P., Donna M. Graham, Anthony W. Tolcher, et al.. (2014). A phase 1b study of combined angiogenesis blockade with nesvacumab, a selective monoclonal antibody (MAb) to angiopoietin-2 (Ang2) and ziv-aflibercept in patients with advanced solid malignancies.. Journal of Clinical Oncology. 32(15_suppl). 2522–2522. 4 indexed citations

17.

Kostić, Ana, Martha E. Anderson, Steven Duniho, et al.. (2014). SGN-LIV1A, an antibody-drug conjugate (ADC), in patients with LIV-1–positive breast cancer.. Journal of Clinical Oncology. 32(15_suppl). TPS1143–TPS1143. 4 indexed citations

18.

Kostić, Ana, et al.. (2013). Intestinal Obstruction in Children. Pediatric Emergency Care. 29(4). 500–501. 9 indexed citations

19.

Kostić, Ana, et al.. (2010). Evaluation of using Alvarado score and C-reactive protein in diagnosing acute appendicitis in children. Vojnosanitetski pregled. 67(8). 644–648. 3 indexed citations

20.

Kostić, Ana, et al.. (2003). OUR EXPERIENCE WITH TUBULARIZED INCISED PLATE URETHROPLASTY FOR DISTAL AND MID-PENILE HYPOSPADIAS. SHILAP Revista de lepidopterología. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact